These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 13438118)

  • 1. [N1-sulfanyl N2-n-butylcarbamide (BZ 55) in the treatment of diabetes mellitus].
    TRAVERSO R; PATELLI R
    Friuli Med; 1956; 11(6, bis):1053-60. PubMed ID: 13438118
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fatal encephalomyelitis after or because of N1-sulfanilyl-N2-n-butylcarbamide therapy of a diabetes case].
    BARTELHEIMER H
    Arztl Wochensch; 1957 Mar; 12(13):283-5. PubMed ID: 13410715
    [No Abstract]   [Full Text] [Related]  

  • 3. [N1-sulfanilyl-N2-n-butylcarbamide therapy of diabetes mellitus].
    DALLE COSTE P; KLINGER R
    Minerva Med; 1956 Sep; 47(76):735-43. PubMed ID: 13387177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Case of very severe allergic reaction in peroral management of diabetes mellitus with a sulfonyl urea derivative, N1-sulfanilyl-N2-n-butylcarbamide].
    FELLER J; KUPPER HJ
    Medizinische; 1956 Nov; 1(46):1641-5. PubMed ID: 13386742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral therapy of diabetes with sulfanyl urea derivatives].
    OTTO H
    Riforma Med; 1957 May; 71(18):489-93. PubMed ID: 13442483
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of carbutamide (BZ-55) and orinase (D860) in the treatment of diabetes mellitus.
    SHEPPE WM
    W V Med J; 1957 Feb; 53(2):70-3. PubMed ID: 13401692
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new antidiabetic N-sulfanilyl-N'-butyl urea (BZ 55); preliminary results].
    CHAIA J
    Rev Med Moyen Orient; 1957; 14(1):47-50. PubMed ID: 13454198
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral management of diabetes mellitus with a sulfonyl-urea derivative, BZ 55].
    BERTRAM F
    Nord Med; 1956 Dec; 56(51):1834-7. PubMed ID: 13400309
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of BZ-55 in the treatment of diabetes].
    BENMUSSA S; NAHUM A
    Presse Med (1893); 1957 Mar; 65(21):469-70. PubMed ID: 13431752
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical results with BZ 55 in the treatment of diabetes].
    ROCCA FF; CASTIGLIONI TRIANON CA; GIANETTO JC
    Dia Med; 1957 May; 29(30):860; passim. PubMed ID: 13447691
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of intravenous & oral N-sulfanilyl-N-butyl urea (BZ 55) on blood sugar in diabetics and persons with normal metabolism].
    PFEFFER KH; FUCHS KJ; MICHEL W; FOERDER HK
    Arztl Wochensch; 1957 Mar; 12(12):260-3. PubMed ID: 13410706
    [No Abstract]   [Full Text] [Related]  

  • 13. [BZ 55 and D 860 in therapy of diabetes mellitus].
    BALDUINI M; BOARI L
    Boll Soc Med Chir Cremona; 1956; 11(1):37-53. PubMed ID: 13412973
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical comparison of carbutamide (BZ 55) and tolbutamide (D 860) treatment of diabetes mellitus; preliminary results of a combined therapy with both drugs].
    INTROZZI P; MARIGO S
    Prog Med (Napoli); 1957 Feb; 13(3):65-72. PubMed ID: 13420208
    [No Abstract]   [Full Text] [Related]  

  • 15. [D 860 (rastinon) and BZ 55 (invenol) in oral therapy of diabetes mellitus].
    MELZER H; SACHSSE B
    Arztl Wochensch; 1956 Nov; 11(48):1058-62. PubMed ID: 13394470
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood crasis, Mommsen granulations and leukocytic glycogen in diabetics treated with N'-sulfanilyl-N2-n-butyl urea].
    PELLEGRINI R; RUMPIANESI G
    Endocrinol Sci Cost; 1956; 23(4):272-8. PubMed ID: 13404963
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypoglycemic coma in diabetics treated with sulfabutyl urea (BZ 55)].
    BUTTARO CA; TRAMONTANA C; GUAITINI V
    Riforma Med; 1957 Apr; 71(16):441-2. PubMed ID: 13442477
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral treatment of diabetes with BZ 55].
    CANESSA I; VALIENTE S; GARCIA DE LOS RIOS M; MELLA I
    Rev Med Chil; 1956 Aug; 84(8):397-407. PubMed ID: 13408724
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of N1-sulfanilyl-N2-n-butylcarbamide in blood and urine].
    BRAUN H; BUCHNER M
    Dtsch Gesundheitsw; 1957 Jan; 12(4):115-7. PubMed ID: 13414479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reaction of intestinal flora to oral diabetes therapy with BZ 55 & D 860].
    BENDFELDT E; ERNST O; FLUGGE R; OTTO H
    Medizinische; 1957 Apr; (17):634-7. PubMed ID: 13430247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.